InfuSystem (INFU) posts updated investor presentation via Reg FD 8-K

Rhea-AI Filing Summary

InfuSystem Holdings, Inc. furnished an updated investor presentation dated October 6, 2025, under a Regulation FD disclosure. The presentation is attached as Exhibit 99.1 to this current report. The company states that the information in this section and in the investor presentation is being furnished rather than filed, so it is not subject to certain liability provisions of the Exchange Act and is not automatically incorporated into other securities law filings.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

0001337013false00013370132025-10-062025-10-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): October 6, 2025

___________________________________

InfuSystem Holdings, Inc.

(Exact name of registrant as specified in its charter)

___________________________________

Delaware (State or other jurisdiction of incorporation or organization)			001-35020 (Commission File Number)			20-3341405 (I.R.S. Employer Identification Number)
3851 West Hamlin Road Rochester Hills, Michigan 48309
(Address of principal executive offices) (Zip Code)
(248) 291-1210
(Registrant's telephone number, including area code)
			Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class			Trading Symbol(s)			Name of Each Exchange on which Registered
Common Stock, par value $.0001 per share			INFU			NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 - Regulation FD Disclosure

InfuSystem Holdings, Inc. (the “Company”) hereby furnishes the information set forth in the Investor Presentation dated October 6, 2025 , which is attached hereto as Exhibit 99.1.

The information furnished in this Item 7.01 — “Regulation FD Disclosure” of this Current Report on Form 8-K and the Investor Presentation attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

Item 9.01 - Financial Statements and Exhibits

(d) Exhibits

Exhibit No.						Description
99.1						InfuSystem Holdings, Inc. Investor Presentation dated October 6, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

INFUSYSTEM HOLDINGS, INC.
By:			/s/ Barry Steele
			Barry Steele
			Chief Financial Officer

Dated: October 6, 2025

FAQ

What did InfuSystem (INFU) disclose in this Form 8-K?

InfuSystem furnished an updated Investor Presentation dated October 6, 2025 as Exhibit 99.1 under a Regulation FD disclosure.

Is the InfuSystem (INFU) investor presentation considered filed with the SEC?

No. InfuSystem states the information in Item 7.01 and Exhibit 99.1 is furnished, not filed, and is not subject to Section 18 liability or automatically incorporated into other filings.

Which SEC item did InfuSystem (INFU) use for this disclosure?

InfuSystem used Item 7.01 – Regulation FD Disclosure to provide the investor presentation to the market.

What exhibits are included with this InfuSystem (INFU) 8-K?

The report lists Exhibit 99.1, InfuSystem Holdings, Inc. Investor Presentation dated October 6, 2025, and Exhibit 104, the cover page interactive data file.

Who signed this InfuSystem (INFU) Form 8-K?

The Form 8-K was signed on behalf of InfuSystem Holdings, Inc. by Barry Steele, Chief Financial Officer.